Ritam Digital English
  • Home
  • Nation
  • World
  • Videos
    • Special Updates
    • Entertainment
    • Legal
    • Business
    • History
    • Viral Videos
  • Politics
  • Business
  • Lifestyle
    • Entertainment
    • Health
    • Food
    • Fashion
    • Viral
  • Sports
  • Opinion
No Result
View All Result
Ritam Digital English
  • Home
  • Nation
  • World
  • Videos
    • Special Updates
    • Entertainment
    • Legal
    • Business
    • History
    • Viral Videos
  • Politics
  • Business
  • Lifestyle
    • Entertainment
    • Health
    • Food
    • Fashion
    • Viral
  • Sports
  • Opinion
No Result
View All Result
Ritam Digital English
No Result
View All Result
  • Home
  • Nation
  • World
  • Videos
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Sci & Tech
  • Sports
  • Opinion
Home Nation

India Fast-Tracks New Drug Approval: Waives Local Clinical Trials for Select Medicines

India Waives Local Clinical Trials for Select Drugs Approved in US, UK, and EU

Editor Ritam English by Editor Ritam English
Aug 8, 2024, 04:56 pm IST
India waives local clinical trials of new drugs: Official sources

India waives local clinical trials of new drugs: Official sources

FacebookTwitterWhatsAppTelegram

In a move, the Indian government has waived the requirement for conducting local clinical trials for certain drugs that have already been approved by regulatory authorities in countries like the United States, the United Kingdom, and the European Union. This decision is aimed at making critical medicines available to Indian patients more quickly.

Many medicines approved in countries like the US, UK, and EU are not immediately accessible to Indian patients due to regulatory requirements under the Drugs and Cosmetics Act. One such requirement is the need to conduct local clinical trials in India to generate safety and efficacy data before these drugs can be marketed in the country. This process often leads to delays in the availability of potentially life-saving drugs.

To address this issue, the government has decided to allow the import and use of certain medicines without the need for local trials under specific conditions. This exemption applies to drugs from countries like the USA, UK, Japan, Australia, Canada, and the EU, provided they meet certain criteria under Rule 101 of the Drugs and Cosmetics Rules.

The types of drugs eligible for this exemption include:

  • Orphan drugs for rare diseases.
  • Gene and cellular therapy products.
  • New drugs used in pandemic situations.
  • New drugs for special defense purposes.
  • Drugs that offer significant therapeutic advances over existing treatments.

The decision is expected to have a significant impact on the availability of advanced treatments for diseases such as cancers, rare genetic disorders like Spinal Muscular Atrophy (SMA) and Duchenne Muscular Dystrophy (DMD), and autoimmune conditions. By bypassing the requirement for local trials, these medicines can be made available to Indian patients much more quickly.

ALSO READ: “Health Ministry Reviews Chandipura Virus and Encephalitis Outbreak in Gujarat, Rajasthan, and Madhya Pradesh”

In addition to improving access to critical medications, this decision is also expected to reduce the cost of public healthcare programs in India. By eliminating the expense of conducting local clinical trials, pharmaceutical companies can pass on the savings to patients, potentially lowering the cost of these medicines. This will benefit various government health schemes like the Central Government Health Scheme (CGHS) and Ayushman Bharat.

While the waiver of local clinical trials will speed up the availability of these drugs, the government has mandated that phase four clinical trials, which monitor the long-term safety and effectiveness of these drugs after they have been introduced to the market, will still be required.

This policy change marks a significant step toward ensuring that Indian patients have faster access to cutting-edge treatments that are already available in other parts of the world. By balancing patient needs with regulatory requirements, the government aims to enhance healthcare outcomes while also managing costs.

Tags: DrugNew Drug ApprovalPillsIndian Government
ShareTweetSendShare

Related News

 If History Had Followed Mukherjee’s Path, What Would India Have Been Like?
Nation

 If History Had Followed Mukherjee’s Path, What Would India Have Been Like?

78 Years Ago Today, British Parliament Passed Indian Independence Act
Nation

78 Years Ago Today, British Parliament Passed Indian Independence Act

July 4, 1947: The Secret Turning Point That Led to India’s Historic Independence a Month Later
Nation

July 4, 1947: The Secret Turning Point That Led to India’s Historic Independence a Month Later

The Death of Swami Vivekananda: A Legacy Beyond Mortality
Nation

The Death of Swami Vivekananda: A Legacy Beyond Mortality

The Sedition Trial of Bal Gangadhar Tilak in 1897: A Watershed in Colonial India’s Repression of Dissent
Nation

The Sedition Trial of Bal Gangadhar Tilak in 1897: A Watershed in Colonial India’s Repression of Dissent

Comments

The comments posted here/below/in the given space are not on behalf of Ritam Digital Media Foundation. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

 If History Had Followed Mukherjee’s Path, What Would India Have Been Like?

 If History Had Followed Mukherjee’s Path, What Would India Have Been Like?

78 Years Ago Today, British Parliament Passed Indian Independence Act

78 Years Ago Today, British Parliament Passed Indian Independence Act

July 4, 1947: The Secret Turning Point That Led to India’s Historic Independence a Month Later

July 4, 1947: The Secret Turning Point That Led to India’s Historic Independence a Month Later

The Death of Swami Vivekananda: A Legacy Beyond Mortality

The Death of Swami Vivekananda: A Legacy Beyond Mortality

The Sedition Trial of Bal Gangadhar Tilak in 1897: A Watershed in Colonial India’s Repression of Dissent

The Sedition Trial of Bal Gangadhar Tilak in 1897: A Watershed in Colonial India’s Repression of Dissent

Shimla Agreement: The Untold Realities Behind a Defining Indo-Pak Treaty

Shimla Agreement: The Untold Realities Behind a Defining Indo-Pak Treaty

A Nation’s Healer and Builder: The Inspiring Legacy of Dr. Bidhan Chandra Roy

A Nation’s Healer and Builder: The Inspiring Legacy of Dr. Bidhan Chandra Roy

What RSS Has Done for Families: From Promoting Fertility to Strengthening Family Values Through Kutumb Prabodhan

What RSS Has Done for Families: From Promoting Fertility to Strengthening Family Values Through Kutumb Prabodhan

How ‘Make in India’ Transformed Indian Manufacturing: A Decade of Massive Growth

How ‘Make in India’ Transformed Indian Manufacturing: A Decade of Massive Growth

Iran-Israel Ceasefire | PM Modi Praises Shubhanshu Shukla | Kharge Criticizes Tharoor | Cloudburst

Iran-Israel Ceasefire | PM Modi Praises Shubhanshu Shukla | Kharge Criticizes Tharoor | Cloudburst

  • Home
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer

© Ritam Digital Media Foundation.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Nation
  • World
  • Videos
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Sci & Tech
  • Sports
  • Opinion
  • About & Policies
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms & Conditions
    • Disclaimer

© Ritam Digital Media Foundation.
Tech-enabled by Ananthapuri Technologies